Personalis, Inc.
(NASDAQ: PSNL)

Personalis, Inc. engages in the provision of advanced genomic tests for cancer. The firm is also involved in providing sequencing and data analysis services to support population sequencing initiatives. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in February 2011 and is headquartered in Fremont, CA.

9.690

-0.790 (-7.54%)
Range 9.430 - 10.480   (11.13%)
Open 10.480
Previous Close 10.480
Bid Price 2.020
Bid Volume 8
Ask Price 2.030
Ask Volume 18
Volume 581,051
Value -
Remark
Delayed prices. Updated at 06 Dec 2025 01:06.
Data powered by
View All Events


Loading Chart...

Please login to view stock data and analysis